New COVID vaccines may be coming to Australia. Here’s what to know about the JN.1 shots
In Australia, our process differs slightly and tends to take a little longer. The TGA’s website indicates applications for ...
GSK says mRNA flu shot shows promise in boost for pipeline
GSK Plc’s experimental mRNA flu vaccine showed a positive immune response against two key types of flu viruses in a mid-stage trial.
FiercePharma13d
As Sandoz contract winds down, GSK will close antibiotics plant in UK
With the expiration of a contract to produce antibiotic medicines for Sandoz, GSK will shutter a 75-year-old manufacturing ...
British drugmaker GSK moves mRNA flu vaccine to late-stage trials
The data showed that a vaccine candidate produced positive immune responses against both A and B flu strains in younger and ...
FierceBiotech10d
GSK's mRNA flu vaccine finally overcomes tricky B strains in phase 2 trial
After an initial defeat against the biggest barrier to mRNA flu vaccines—namely, B strains of influenza—GSK has returned with a reformulated candidate that has ...
Daily9d
After positive midstage trial, GSK moves mRNA flu vaccine to late-stage trials
British drugmaker GSK announced on Thursday positive results from a mid-stage trial of its seasonal influenza vaccine ...
COVID-19
Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...
The Financial Express10d
GSK moves mRNA flu vaccine to late-stage trials following positive outcomes
GSK bought partner CureVac out of their alliance on influenza and COVID-19 vaccine development, boosting its messenger RNA credentials.
PipelineReview.com10d
GSK announces positive headline data from phase II seasonal influenza mRNA vaccine programme
LONDON, UK I 12, 2024 I GSK plc (LSE/NYSE: GSK) today announced positive headline results of a phase II trial (NCT06431607) for its mRNA seasonal ...